Søren Morgenthaler Echwald

Amministratore Delegato presso Anapa Biotech A/S

Commercial Services

Profilo

Søren Morgenthaler Echwald is currently the Chief Executive Officer at Anapa Biotech A and a Director at Ranger Biotechnologies A.
He was previously the Vice President-Business Development at Exiqon A.

Posizioni attive di Søren Morgenthaler Echwald

Società	Posizione	Inizio
Anapa Biotech A/S Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark.	Amministratore Delegato	-
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Søren Morgenthaler Echwald

Precedenti posizioni note di Søren Morgenthaler Echwald

Società	Posizione	Fine
EXIQON A/S	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Søren Morgenthaler Echwald

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Søren Morgenthaler Echwald

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Exiqon A/S Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark.	Commercial Services
Anapa Biotech A/S Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark.	Commercial Services
Ranger Biotechnologies A/S Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark.	Commercial Services

Vedi le connessioni aziendali